Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study.
Claire F VerschraegenGuy JerusalemEdward F McClayNicholas IannottiCharles H RedfernJaafar BennounaFranklin L ChenKaren KellyJanice MehnertJohn C MorrisMatthew TaylorDavid SpigelDing WangHans Juergen GroteDongli ZhouNeru MunshiMarcis BajarsJames L GulleyPublished in: Journal for immunotherapy of cancer (2021)
ClinicalTrials.gov NCT01772004; registered January 21, 2013.